Because the disease is becoming increasingly resistant to existing medications, a group of UCF researchers is attempting to use cancer pharmaceuticals to accelerate the development of new, life-saving malaria treatments. The study's findings were published in the journal ACS Infectious Disea
A group of UCF researchers are looking to use cancer pharmaceuticals to hasten the development of fresh, life-saving malaria treatments because the disease is getting more and more resistant to existing medications.